Abstract

BackgroundImmunomodulatory drugs represent the best therapeutic option in first-line treatment of relapsing-remitting multiple sclerosis (RRMS). This group includes glatiramer acetate (GA) and three formulations of Interferon β (IFNβ): subcutaneous IFNβ1a...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies
Claudio Gobbi ... Martin Traber
European neurology | VOL. 70
Claudio Gobbi, et. al.Claudio Gobbi ... Martin Traber
14 May 2013
Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis
Alison Huggins ... Robert C Sergott
Current Opinion In Ophthalmology | VOL. 22
Alison Huggins, et. al.Alison Huggins ... Robert C Sergott
01 Nov 2011
Treatment Discontinuation and Disease Progression with Injectable Disease-Modifying Therapies
Robert J Fox ... Xiaojun You
International journal of MS care | VOL. 15
Robert J Fox, et. al.Robert J Fox ... Xiaojun You
31 Dec 2014
Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry
Stefan Braune ... Fabio Pellegrini
Journal of neurology | VOL. 265
Stefan Braune, et. al.Stefan Braune ... Fabio Pellegrini
16 Oct 2018
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
A single harmonised pharmacy process to improve clinical trial set-up times
Miriam Lettieri ... Beatriz Duran Jimenez
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Miriam Lettieri, et. al.Miriam Lettieri ... Beatriz Duran Jimenez
27 Jun 2024
Potential medicine waste in the process of outpatients receiving cost-free medicines from medicine pick-up lockers in the North Denmark region
Lisa Greve Routhe ... Anne Estrup Olesen
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lisa Greve Routhe, et. al.Lisa Greve Routhe ... Anne Estrup Olesen
26 Jun 2024
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients
Yan Yan ... Ji Wu
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Yan Yan, et. al.Yan Yan ... Ji Wu
19 Jun 2024
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK
Stephen Morris ... Andrew Salm
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Stephen Morris, et. al.Stephen Morris ... Andrew Salm
14 Jun 2024
View more papers